Cargando…

Augmented concentrations of CX(3)CL1 are associated with interstitial lung disease in systemic sclerosis

BACKGROUND: Dysregulation of Fractalkine (CX(3)CL1) and its receptor CX(3)CR1 has been linked to the pathobiology of chronic inflammatory conditions. We explored CX(3)CL1 in systemic sclerosis (SSc) related progressive interstitial lung disease (ILD) and pulmonary hypertension (PH) in two different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoffmann-Vold, Anna-Maria, Weigt, Stephen Samuel, Palchevskiy, Vyacheslav, Volkmann, Elizabeth, Saggar, Rajan, Li, Ning, Midtvedt, Øyvind, Lund, May Brit, Garen, Torhild, Fishbein, Michael C., Ardehali, Abbas, Ross, David J., Ueland, Thor, Aukrust, Pål, Lynch, Joseph P., Elashoff, Robert M., Molberg, Øyvind, Belperio, John A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245508/ https://www.ncbi.nlm.nih.gov/pubmed/30457999 http://dx.doi.org/10.1371/journal.pone.0206545

Ejemplares similares

Serum markers of cardiac complications in a systemic sclerosis cohort
por: Tennøe, Anders H., et al.
Publicado: (2022)

Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension
por: Didriksen, Henriette, et al.
Publicado: (2022)

Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study
por: Reiseter, Silje, et al.
Publicado: (2015)

Endotype–phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2019)

Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort
por: Vikse, Jens, et al.
Publicado: (2023)

Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort
por: Fretheim, Håvard, et al.
Publicado: (2020)

Systolic Dysfunction in Systemic Sclerosis: Prevalence and Prognostic Implications
por: Tennøe, Anders H., et al.
Publicado: (2019)

The prognostic importance of CXCR3 chemokine during organizing pneumonia on the risk of chronic lung allograft dysfunction after lung transplantation
por: Shino, Michael Y., et al.
Publicado: (2017)

Gastrointestinal symptom severity and progression in systemic sclerosis
por: van Leeuwen, Nina M, et al.
Publicado: (2022)

Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial
por: Fretheim, Håvard, et al.
Publicado: (2020)

Comparative analyses of muscle MRI and muscular function in anti-synthetase syndrome patients and matched controls: a cross-sectional study
por: Andersson, Helena, et al.
Publicado: (2017)

Protection against Bronchiolitis Obliterans Syndrome Is Associated with Allograft CCR7(+)CD45RA(−) T Regulatory Cells
por: Gregson, Aric L., et al.
Publicado: (2010)

Gene Expression Profiling of Bronchoalveolar Lavage Cells Preceding a Clinical Diagnosis of Chronic Lung Allograft Dysfunction
por: Weigt, S. Samuel, et al.
Publicado: (2017)

Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis
por: Palchevskiy, Vyacheslav, et al.
Publicado: (2011)

Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis
por: Strahm, Noemi, et al.
Publicado: (2023)

Preoperative Cardiac Variables of Diastolic Dysfunction and Clinical Outcomes in Lung Transplant Recipients
por: Yadlapati, Ajay, et al.
Publicado: (2013)

The Impact of Allograft CXCL9 during Respiratory Infection on the Risk of Chronic Lung Allograft Dysfunction
por: Shino, Michael Y., et al.
Publicado: (2018)

Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts
por: Volkmann, Elizabeth R, et al.
Publicado: (2017)

Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2021)

TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study
por: Gudbrandsson, Birgir, et al.
Publicado: (2017)

Extrapulmonary sarcoidosis with a focus on cardiac, nervous system, and ocular involvement
por: Belperio, John A., et al.
Publicado: (2021)

Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study
por: Reiseter, Silje, et al.
Publicado: (2017)

The relationship between Fibroblast Growth Factor 23 (FGF23) and cardiac MRI findings following primary PCI in patients with acute first time STEMI
por: Thorsen, Inga Strand, et al.
Publicado: (2021)

Modulating neurotoxicity through CX3CL1/CX3CR1 signaling
por: Limatola, Cristina, et al.
Publicado: (2014)

The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
por: Pawelec, Paulina, et al.
Publicado: (2020)

Fractalkine/CX3CL1 in Neoplastic Processes
por: Korbecki, Jan, et al.
Publicado: (2020)

Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout mice
por: Winter, Aimee N., et al.
Publicado: (2020)

CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection
por: Chen, Peiqing, et al.
Publicado: (2016)

Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis
por: Wojdasiewicz, Piotr, et al.
Publicado: (2019)

CX3CL1 intracellular domain and adult neurogenesis
por: Benoit, Marc R., et al.
Publicado: (2019)

Involvement of CX3CL1/CX3CR1 Signaling in Spinal Long Term Potentiation
por: Bian, Chao, et al.
Publicado: (2015)

Regulation and function of CX3CR1 and its ligand CX3CL1 in kidney disease
por: von Vietinghoff, Sibylle, et al.
Publicado: (2021)

Long-Term Outcome in Systemic Lupus Erythematosus; Knowledge from Population-Based Cohorts
por: Reppe Moe, Sigrid, et al.
Publicado: (2021)

CCL21 and prognosis in acute coronary syndrome
por: Ueland, Thor, et al.
Publicado: (2019)

Hydrogen Sulfide Inhibits the Development of Atherosclerosis with Suppressing CX3CR1 and CX3CL1 Expression
por: Zhang, Huili, et al.
Publicado: (2012)

CX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe?
por: Zhuang, Quan, et al.
Publicado: (2017)

CX3CL1–CX3CR1 Axis: A New Player in Coeliac Disease Pathogenesis
por: Fernández-Prieto, Marta, et al.
Publicado: (2019)

Developing drugs targeting CX3CL1 to treat heart diseases via immune/inflammatory mediation: Targeting CX3CL1 to treat heart diseases
por: Zou, Lin, et al.
Publicado: (2023)

Usefulness of gene expression profiling of bronchoalveolar lavage cells in acute lung allograft rejection
por: Weigt, S. Samuel, et al.
Publicado: (2019)

The Chemokine CX3CL1 (Fractalkine) and its Receptor CX3CR1: Occurrence and Potential Role in Osteoarthritis
por: Wojdasiewicz, Piotr, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mteq866ji5g8lrfhgofge72s9d